Filter
363
Filtered Results: 363
Text search:
National
Pharmacovigilance
Policy
Featured
Recommendations
41
New Publications
130
Language
Document type
No document type
207
Guidelines
56
Studies & Reports
45
Strategic & Response Plan
20
Manuals
18
Fact sheets
7
Training Material
5
Situation Updates
4
Infographics
1
Countries / Regions
Kenya
21
Nigeria
15
Ghana
14
Uganda
14
India
14
Western and Central Europe
13
Rwanda
11
Global
11
Eastern Europe
11
Nepal
10
South Africa
10
Namibia
9
Ethiopia
8
Sierra Leone
7
Malawi
7
Tanzania
6
Philippines
5
Congo, Democratic Republic of
5
South–East Asia Region
5
Liberia
5
Africa
4
Cambodia
4
West and Central Africa
4
Bangladesh
4
Russia
4
Zambia
4
Lesotho
3
Benin
3
Senegal
3
Zimbabwe
3
Mozambique
3
Latin America and the Carribbean
3
East and Southern Africa
3
Botswana
3
Ukraine
2
Syria
2
Haiti
2
Asia
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Sudan
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Cameroon
1
Laos
1
Burkina Faso
1
Afghanistan
1
Guinea
1
Jordan
1
Western Pacific Region
1
Maldives
1
Lebanon
1
Sri Lanka
1
Yemen
1
Georgia
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
65
Policies
58
Policies & Guidelines HIV & TB
37
Guidelines
34
Studies & Reports
18
Women & Child Health
10
TB
10
NTDs & Others
8
Malaria
8
Statistics
6
Pharmacy & Technology
5
COVID-19
4
Countries
4
Non-communicable Diseases
4
HIV & STI
4
Disease Prevention & Control
4
Communicable Diseases
3
Hepatitis
3
Vaccine-preventable Diseases
3
Community Health
3
Capacity Building
3
Taeniasis/ Cysticercosis
2
Snakebites
2
Pharmaceutical Assessments
2
NCD
2
Medical Devices & Equipment
2
Immunization
2
General Guidelines
2
Leprosy
2
Paediatrics
1
Clinical Training
1
Rabies
1
Helminthiasis
1
Under-5 nutrition
1
Disaster Preparedness
1
Trachoma
1
Onchocerciasis
1
Schistosomiasis
1
Dermatology
1
Lymphaticfilariasis
1
Cancer
1
Vector Control
1
Community Health
1
Pediatric cancer
1
Non-communicable Diseases NCD
1
Public Health
1
Pediatrics
1
Cardiovascular Diseases
1
Clinical Guidelines
1
Demograhic Health Surveys DHS
1
Other
1
Respiratory Infections
1
Communicable Diseases
1
Health Systems
1
Maternal Health
1
Primary Health Care
1
Dengue
1
Leishmaniasis
1
Laboratory Quality Assurance
1
Key Resources
1
Global Health
1
Pharmacy & Technologies
1
Toolboxes
Country specific
15
Rational use of Medicine
11
Drug resistant TB
11
Access & Strategy
8
Pharmacovigilance
8
Reports & Studies
7
Essential Medicines
6
Falsified & Substandard
5
Traditional & Herbal Medicines
5
Antiretroviral Treatment ART
5
Clinical Aspects, Treatment & Prevention
4
Clinical Guidelines
4
Supporting tools
4
Country Specific
4
Immunization Guidelines
4
Eastern Europe & Central Asia
4
SEAR (South-east Asia Region)
4
Adults
3
Hospital Readiness/Essential Health Services
3
Inactivated COVID-19 Vaccines
3
Essential Medicines & Devices Lists
3
General Guidelines for Rational Use
3
Overview, Studies & Reports
3
Research & Access
3
Western & Central Europe
3
Treatment & Prevention
2
Preparedness, Response & Risk Communication
2
Prevention & Control
2
Children & Adolescents
2
WPRO (Western Pacific Region)
2
Children
2
Georgia
2
Drug resistance
2
Ethiopia
2
International
2
Prevention & Preparedness
2
Studies
2
General
2
Oxygen Therapy
2
Logistics & Supply
2
Prices and Patents
2
Pharmaceutical Assessments
2
Pharmacy Practice
2
One Health
2
Waste Managment
2
Studies & Reports
2
Education of students & professionals
2
Uganda
2
HIV service delivery
2
Reports & Studies
2
Eastern Europe and central Asia
2
Outbreak Prevention & Control
1
Clinical Guidelines
1
Childhood TB
1
Agriculture & Veterinary
1
Clinical Guidelines
1
Azerbaijan
1
Clinical Aspects
1
Vaccination
1
Ukraine
1
South Africa
1
Influenza
1
Treatment Guidelines HIV
1
Namibia
1
Public Health
1
HIV
1
Prevention & Control
1
Rwanda
1
Research
1
Vaccination
1
TB & Other Vulnerable Populations
1
Country Guidelines
1
Belarus
1
Reports
1
Russia
1
Health Personnel
1
Infection Control General
1
Surveillance & Contact tracing
1
For Pregnant Women
1
Training, others
1
Appeals and Response Plans
1
Gender Aspects
1
Communication Material
1
TB/HIV
1
Fair Allocation & Ethical Aspects
1
COVAX Initiative
1
Biontech/Pfizer Comirnaty
1
Vaxzevria (Astra Zeneca)
1
Johnson & Johnson
1
Standard Operating Procedure (SOP)
1
Midwives
1
Pharmacy Management
1
Quality Assurance
1
Antimicrobial Resistance (AMR)
1
Waste management
1
Leishmaniasis
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Patient Safety
1
Clinical Aspects & Diagnosis
1
Clinical Aspects & Diagnosis
1
Prevention & Strategies
1
Clinical Aspects & Diagnosis
1
Diagnosis
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Romania
1
Asia and Pacific
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
General Aspects
1
Human Rights & the Right to Health
1
TB & Prisoners
1
Training
1
General Public
1
TB/HIV Coinfection
1
Clinical Guidelines
1
Kazakhstan
1
AmR (Region of Americas)
1
TB
1
Reports & Studies Children HIV
1
Kenya
1
Meningitis & Encephalitis
1
Preparedness & Prevention
1
Treatment & Clinical Management
1
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
The core of the strategy is the goal for all patients to have better overall care, so that the numbers of deaths and cases of disability are reduced by 50% before 2030. For this to be achieved, four strategic aims will be pursued.
Empower and engage communities,
Ensure safe, effective tre...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
The goal of the United States Government for the President's Emergency Plan for AIDS Relief (PEPFAR) in Mozambique is to support country efforts to achieve epidemic control by 2020 through evidence-based policies and interventions to drive progress and save
lives. This document details PEPFAR's op...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
Kenya Quality Model for Health - Health Facilities
Waste Management & Research 39(1) DOI: 10.1177/0734242X211029175
The World Health Organization's fourth Country Cooperation Strategy 2022-2026 is an outcome of a consultative process with inputs from the Ministry of Health, various agencies in the health sector, and other relevant stakeholders. It has been developed to provide strategic direction and support towa...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
Disability inclusive shelter programming enables persons with disabilities to contribute more to their communities, participate more in consultations and decision-making, and facilitate their own protection. The key concepts include: Disability inclusive shelter programming is both a process and an ...
